Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Scientists at Innate Pharma divulge new MAbs for cancer

Aug. 29, 2013

Health Canada approves Roche's Erivedge for advanced basal cell carcinoma

Aug. 28, 2013

Novel lung cancer vaccine CV-9202 evaluated in phase I trial

Aug. 23, 2013

Generation of a human anticancer immune response using a dendritic cell-based vaccine

Aug. 22, 2013

MacroGenics doses first patient in phase I MGA-271 trial

Aug. 21, 2013

Patient enrolled in brain tumor vaccine trial at Northwestern Memorial Hospital

Aug. 19, 2013

Amorfix Life Sciences provides update on ovarian cancer program

Aug. 19, 2013

ADXS-HPV receives orphan drug designation for HPV-associated anal cancer

Aug. 19, 2013

Phase II trial of Adcetris in combination with standard of care for frontline DLBCL commences

Aug. 19, 2013

Altor receives IND clearance to advance ALT-803 into clinical trials in melanoma

Aug. 16, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...